aserenucleation of Prostate Glands > 60g
- Conditions
- N40Hyperplasia of prostate
- Registration Number
- DRKS00000787
- Lead Sponsor
- Asklepios Klinik BarmbekAbteilung für Urologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting stopped after recruiting started
- Sex
- Male
- Target Recruitment
- 120
Inclusion Criteria
IPSS-Score = 8
Uroflow: Qmax = 15ml/s
Urodynamic: Schäfer-Scale = II°
Prostate volume measured by transrectal ultrasoundl (TRUS) = 60 ml
Exclusion Criteria
Known urethral or prostate surgery
Voiding symptoms not referred to BPO (Striktur)
Known Prostate Cancer
Neurogenic Bladder
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method primary outcome: <br>improvement of Qmax and IPSS score<br>minimal improvement: <br>- Qmax 3 ± 5 ml/s <br>- minimum decrease of IPSS-Score: 2 points. <br><br>Follow-up visit:<br>- 3, 6 months, 1, 2 und 5 years after surgery
- Secondary Outcome Measures
Name Time Method intra and postoperative complications<br>during follow up. <br><br>Follow-up visit:<br>- 3, 6 months, 1, 2 und 5 years after surgery